Care Property Invest NV

ENXTBR:CPINV Stock Report

Market Cap: €449.0m

Care Property Invest Valuation

Is CPINV undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CPINV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CPINV (€12.14) is trading below our estimate of fair value (€38.22)

Significantly Below Fair Value: CPINV is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CPINV?

Key metric: As CPINV is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CPINV. This is calculated by dividing CPINV's market cap by their current revenue.
What is CPINV's PS Ratio?
PS Ratio6.4x
Sales€70.18m
Market Cap€449.04m

Price to Sales Ratio vs Peers

How does CPINV's PS Ratio compare to its peers?

The above table shows the PS ratio for CPINV vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average6x
HOMI Home Invest Belgium
8.3x2.8%€314.5m
XIOR Xior Student Housing
6.1x-0.7%€1.3b
NEXTA Nextensa/SA
3.4x14.9%€424.5m
WEHB Wereldhave Belgium
6.1x0.4%€412.3m
CPINV Care Property Invest
6.4x3.9%€449.0m

Price-To-Sales vs Peers: CPINV is expensive based on its Price-To-Sales Ratio (6.4x) compared to the peer average (6x).


Price to Sales Ratio vs Industry

How does CPINV's PS Ratio compare vs other companies in the European Residential REITs Industry?

1 CompanyPrice / SalesEstimated GrowthMarket Cap
CPINV 6.4xIndustry Avg. 8.9xNo. of Companies5PS0612182430+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: CPINV is good value based on its Price-To-Sales Ratio (6.4x) compared to the European Residential REITs industry average (8.8x).


Price to Sales Ratio vs Fair Ratio

What is CPINV's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CPINV PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio6.4x
Fair PS Ratio8x

Price-To-Sales vs Fair Ratio: CPINV is good value based on its Price-To-Sales Ratio (6.4x) compared to the estimated Fair Price-To-Sales Ratio (8x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CPINV forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€12.14
€15.63
+28.7%
4.7%€16.50€14.50n/a4
Nov ’25€12.40
€15.50
+25.0%
4.6%€16.50€14.50n/a4
Oct ’25€14.34
€15.50
+8.1%
4.6%€16.50€14.50n/a4
Sep ’25€14.58
€15.50
+6.3%
4.6%€16.50€14.50n/a4
Aug ’25€13.88
€15.50
+11.7%
4.6%€16.50€14.50n/a4
Jul ’25€13.38
€15.50
+15.8%
4.6%€16.50€14.50n/a4
Jun ’25€13.90
€15.50
+11.5%
4.6%€16.50€14.50n/a4
May ’25€13.94
€15.13
+8.5%
2.7%€15.50€14.50n/a4
Apr ’25€13.20
€15.13
+14.6%
2.7%€15.50€14.50n/a4
Mar ’25€12.32
€15.25
+23.8%
1.6%€15.50€15.00n/a4
Feb ’25€13.16
€15.25
+15.9%
1.6%€15.50€15.00n/a4
Jan ’25€14.26
€15.13
+6.1%
4.9%€16.00€14.00n/a4
Dec ’24€13.06
€15.13
+15.8%
4.9%€16.00€14.00n/a4
Nov ’24€11.54
€15.38
+33.2%
2.7%€16.00€15.00€12.404
Oct ’24€11.88
€16.38
+37.8%
12.8%€20.00€15.00€14.344
Sep ’24€12.20
€16.88
+38.3%
12.3%€20.00€15.00€14.584
Aug ’24€12.72
€16.67
+31.0%
14.1%€20.00€15.00€13.883
Jul ’24€12.34
€19.00
+54.0%
15.5%€22.00€15.00€13.383
Jun ’24€12.58
€19.00
+51.0%
15.5%€22.00€15.00€13.903
May ’24€13.64
€19.50
+43.0%
23.1%€24.00€15.00€13.942
Apr ’24€12.74
€19.50
+53.1%
23.1%€24.00€15.00€13.202
Feb ’24€14.12
€29.50
+108.9%
18.6%€35.00€24.00€13.162
Jan ’24€15.76
€35.33
+124.2%
5.8%€38.00€33.00€14.263
Dec ’23€14.96
€34.63
+131.5%
6.2%€38.00€32.50€13.064
Nov ’23€16.78
€34.63
+106.3%
6.2%€38.00€32.50€11.544

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies